Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures

Open access
ARKACHAISRI, THASCHAWEE, VILAIYUK, SOAMARAT, LI, SUZANNE, O’NEIL, KATHLEEN M., POPE, ELENA, HIGGINS, GLORIA C., PUNARO, MARILYNN, RABINOVICH, EGLA C., ROSENKRANZ, MARGALIT, KIETZ, DANIEL A., ROSEN, PAUL, SPALDING, STEVEN J., HENNON, TERESA R., TOROK, KATHRYN S., CASSIDY, ELAINE, MEDSGER, THOMAS A.·2009·The Journal of Rheumatology

Abstract

Objective.: To develop and evaluate a Localized Scleroderma (LS) Skin Severity Index (LoSSI) and global assessments’ clinimetric property and effect on quality of life (QOL). Methods.: A 3-phase study was conducted. The first phase involved 15 patients with LS and 14 examiners who assessed LoSSI [surface area (SA), erythema (ER), skin thickness (ST), and new lesion/extension (N/E)] twice for inter/intrarater reliability. Patient global assessment of disease severity (PtGA-S) and Children’s Dermatology Life Quality Index (CDLQI) were collected for intrarater reliability evaluation. The second phase was aimed to develop clinical determinants for physician global assessment of disease activity (PhysGA-A) and to assess its content validity. The third phase involved 2 examiners assessing LoSSI and PhysGA-A on 27 patients. Effect of training on improving reliability/validity and sensitivity to change of the LoSSI and PhysGA-A was determined. Results.: Interrater reliability was excellent for ER [intraclass correlation coefficient (ICC) 0.71], ST (ICC 0.70), LoSSI (ICC 0.80), and PhysGA-A (ICC 0.90) but poor for SA (ICC 0.35); thus, LoSSI was modified to mLoSSI. Examiners’ experience did not affect the scores, but training/practice improved reliability. Intrarater reliability was excellent for ER, ST, and LoSSI (Spearman’s rho = 0.71–0.89) and moderate for SA. PtGA-S and CDLQI showed good intrarater agreement (ICC 0.63 and 0.80). mLoSSI correlated moderately with PhysGA-A and PtGA-S. Both mLoSSI and PhysGA-A were sensitive to change following therapy. Conclusion.: mLoSSI and PhysGA-A are reliable and valid tools for assessing LS disease severity and show high sensitivity to detect change over time. These tools are feasible for use in routine clinical practice. They should be considered for inclusion in a core set of LS outcome measures for clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3899/jrheum.081284

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 183

Metadata

Authors
ARKACHAISRI, T., VILAIYUK, S., LI, S., O’NEIL, K. M., POPE, E., HIGGINS, G. C., PUNARO, M., RABINOVICH, E. C., ROSENKRANZ, M., KIETZ, D. A., ROSEN, P., SPALDING, S. J., HENNON, T. R., TOROK, K. S., CASSIDY, E., & MEDSGER, T. A.
Venue
The Journal of Rheumatology
Published
2009-10-15
Volume
36
Issue
12
Pages
2819-2829
ISSN
  • 0315-162X (ISSN-L)
  • 1499-2752
OpenAlex
W2158781546
Cited by
183
References
4
FWCI
4.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures. https://app.cochat.ai/papers/10.3899/jrheum.081284
The paper
ARKACHAISRI, T., VILAIYUK, S., LI, S., O’NEIL, K. M., POPE, E., HIGGINS, G. C., PUNARO, M., RABINOVICH, E. C., ROSENKRANZ, M., KIETZ, D. A., ROSEN, P., SPALDING, S. J., HENNON, T. R., TOROK, K. S., CASSIDY, E., & MEDSGER, T. A. (2009). The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures. The Journal of Rheumatology. https://doi.org/10.3899/jrheum.081284

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.